Ickowicz S, Dong H, Ti L, Nolan S, Fairbairn N, Barrios R, Milloy MJ Behavioural, social and structural-level risk factors for developing AIDS among HIV-positive people who use injection drugs in a Canadian setting, 1996-2017 AIDS Care PubMed

Reddon H, Grant C, Nosova E, Fairbairn N, Barrios R, Justice A, Nolan S, Socías ME, Milloy MJ The Veterans Aging Cohort Study (VACS) Index predicts mortality in a community-recruited cohort of HIV-positive people who use illicit drugs Clin Infect Dis PubMed

Brar R, Fairbairn N, Colizza K, Ryan A, Nolan S Hospital initiated injectable opioid agonist therapy for the treatment of severe opioid use disorder: a case series J Addict Med PubMed

Liang J, Nosova E, Reddon H, Nolan S, Socías ME, Barrios R, Milloy MJ Longitudinal patterns of illicit drug use, ART exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs AIDS PubMed

Braithwaite V, Fairgrieve C, Nolan S Sustained-release oral hydromorphone for the treatment of opioid use disorder J Addict Med PubMed

Brar R, Fairbairn N, Sutherland C, Nolan S Use of a novel prescribing approach for the treatment of opioid use disorder: buprenorphine/naloxone micro-dosing - a case series Drug Alcohol Rev PubMed

Ronsley C, Nolan S, Knight R, Hayashi K, Klimas J, Walley A, Wood E, Fairbairn N Treatment of stimulant use disorder: a systematic review of reviews PLoS One PubMed

Socías ME, Nolan S Can extended-release injectable medications help curb United States and Canada's opioid overdose epidemic? J Addict Med PubMed

Caulfield MDG, Brar R, Sutherland C, Nolan S Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach BMJ Case Rep PubMed

Ickowicz S, Brar R, Nolan S Case study: naltrexone for the treatment of nitrous oxide use J Addict Med PubMed